Aarti Drugs Limited
₹469.35
INR+1.95(+0.42%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹4424.77 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹4978.85 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
29.29
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.86
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
34.15%
Operating Margin
Operating income as a percentage of revenue
9.16%
Return on Equity
Net income as a percentage of shareholders' equity
12.24%
Revenue (TTM)
Total revenue over trailing 12 months
₹2379.61 Cr-6.7%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹295.66 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹16.55-11.600000000000001%
Balance Sheet
Total Cash
Total cash and short-term investments
₹29.56 Cr
Total Debt
Total short-term and long-term debt
₹590.10 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
46.18%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹431.05 - ₹635
Beta
Measure of stock's volatility compared to the market
0.84
Shares Outstanding
Total number of shares issued by the company
₹9.13 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.83%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
6.04%